NIH-funded research R21 grant

Exploring how certain fungi can protect against radiation damage

Official title: Identifying the radioprotective potential of radiation-resistant fungi using Drosophila

Funded at Henry M. Jackson Fdn for the Adv Mil/med · NIH-10811346 · Data updated 2026-11-12

This study is exploring how certain fungi that can survive radiation might help protect sensitive cells in our bodies, like those in the bone marrow and gut, by feeding them to fruit flies and seeing if they reduce radiation damage.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionHenry M. Jackson Fdn for the Adv Mil/med
NIH-funded
Lab location1 site (Bethesda, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$239,363
NIH project number1R21OD034471-01A1
Project IDNIH-10811346 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals who are at risk of radiation exposure, such as astronauts or those living near nuclear facilities.

Less likely to help

Patients who are not exposed to radiation or those with conditions that contraindicate the consumption of fungi may not benefit from this research.

What this research studies

This research investigates the potential of radiation-resistant fungi to protect against the harmful effects of ionizing radiation, particularly in vulnerable cells like those in the bone marrow and gut. By using Drosophila, a type of fruit fly that naturally consumes fungi, the study aims to assess how these fungi can mitigate radiation damage. The approach involves dietary administration of these fungi to observe their protective effects in a controlled model system that shares similarities with human biology.

Why it matters

Potential benefit: If successful, this research could lead to new dietary interventions that help protect patients from radiation exposure, especially in scenarios involving nuclear incidents or space travel.

How similar studies have gone: While the use of fungi for radioprotection is a novel approach, there have been successful studies exploring the radioprotective properties of various biological models, indicating potential for this line of investigation.

Where this research is happening

  • Henry M. Jackson Fdn for the Adv Mil/med
    Bethesda, United States
    Active

Researchers

  • Principal investigator: Cox, Rachel Tafel — Henry M. Jackson Fdn for the Adv Mil/med
  • Study coordinator: Cox, Rachel Tafel

Related research

Other NIH-funded projects on the same topics.

  • Cooperation partners of SETBP1 in AML development

    This grant explores how SETBP1 and AF9 (MLLT3) work together to drive acute myeloid leukemia and whether targeting related epigenetic regulators could help treat aggressive CK-AML.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11625528

  • U.S. Military HIV Research Program Clinical Trials Unit expansion

    A nationwide network of clinical trial sites is being expanded to test HIV prevention and treatment approaches through DAIDS-supported trials.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11609389

  • Novel protein biomarkers of chronic pain in adults using a pain registry biobank

    A study in adults with chronic pain will look for new protein biomarkers in blood samples to understand better why pain persists and how to improve treatment.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11498721

  • Tailored antibody cures for HIV using AI and vaccines

    A study to design personalized antibody-based strategies to achieve HIV remission, using lab experiments and computer models to tailor vaccines or antibody treatments to individuals or small groups.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11483233

  • Understanding how antibody protection works using 3D protein structures

    Researchers will build a 3D-based method to see which viral features relate to prevention by antibodies, using data from people in HIV vaccine and monoclonal antibody trials.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11470978

  • Military HIV Clinical Network

    This program runs HIV and TB prevention and treatment clinical studies for adults in military-associated and high-HIV-burden communities.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11459071

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.